We estimate that the President and CEO of Esperion Therapeutics, Inc. ($ESPR), Sheldon L. Koenig, received a compensation of $3,535,512 in 2025. This is an increase of 10.19% from an estimated $3,175,240 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 16, 2026. Note that parsing errors may occur.
You can track $ESPR on Quiver Quantitative's $ESPR stock dashboard.
$ESPR Stock Insider Trading Activity
$ESPR Stock insiders have traded $ESPR stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ESPR stock by insiders over the last 6 months:
- SHELDON L. KOENIG (President and CEO) has made 0 purchases and 2 sales selling 73,822 shares for an estimated $246,746.
- BENJAMIN LOOKER (Chief Legal Officer) has made 0 purchases and 4 sales selling 15,162 shares for an estimated $47,469.
- BENJAMIN HALLADAY (Chief Financial Officer) has made 0 purchases and 2 sales selling 13,761 shares for an estimated $44,281.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ESPR Stock Hedge Fund Activity
We have seen 117 institutional investors add shares of $ESPR Stock stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. added 6,694,850 shares (+3208.9%) to their portfolio in Q4 2025, for an estimated $24,770,945
- ORBIMED ADVISORS LLC added 5,965,498 shares (+inf%) to their portfolio in Q4 2025, for an estimated $22,072,342
- EVERSEPT PARTNERS, LP added 3,851,133 shares (+inf%) to their portfolio in Q4 2025, for an estimated $14,249,192
- MILLENNIUM MANAGEMENT LLC added 2,957,418 shares (+303.4%) to their portfolio in Q4 2025, for an estimated $10,942,446
- MARSHALL WACE, LLP added 2,950,172 shares (+117.0%) to their portfolio in Q4 2025, for an estimated $10,915,636
- VANGUARD GROUP INC added 2,853,005 shares (+23.6%) to their portfolio in Q4 2025, for an estimated $10,556,118
- BLACKROCK, INC. added 2,848,410 shares (+19.2%) to their portfolio in Q4 2025, for an estimated $10,539,117
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ESPR Stock Analyst Ratings
Wall Street analysts have issued reports on $ESPR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/25/2025
To track analyst ratings and price targets for $ESPR Stock, check out Quiver Quantitative's $ESPR forecast page.
$ESPR Stock Price Targets
Multiple analysts have issued price targets for $ESPR recently. We have seen 3 analysts offer price targets for $ESPR in the last 6 months, with a median target of $5.0.
Here are some recent targets:
- Jason N. Butler from Citizens set a target price of $5.0 on 03/13/2026
- Serge Belanger from Needham set a target price of $5.0 on 03/03/2026
- David Amsellem from Piper Sandler set a target price of $9.0 on 11/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
